The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Several major antiepileptic drugs are substrates for human P-glycoprotein
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early Identification of Refractory Epilepsy
Kwan, P., & Brodie, M. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420503 · Cited by 5,204
A family of drug transporters: the multidrug resistance-associated proteins
Borst, P., Evers, R., Kool, M., & Wijnholds, J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1295 · Cited by 1,751
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00169-2 · Cited by 1,386
Induction of phase I, II and III drug metabolism/transport by xenobiotics
Xu, C., Li, C. Y.-T., & Kong, A.-N. T. (2005) · Archives of Pharmacal Research · doi:10.1007/bf02977789 · Cited by 1,279
Schinkel, A. H., Wagenaar, E., Mol, C. A., & van Deemter, L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118699 · Cited by 1,264
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.027 · Cited by 1,231
Schinkel, A. H., Wagenaar, E., van Deemter, L., Mol, C. A., & Borst, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118214 · Cited by 1,107
Drug resistance in brain diseases and the role of drug efflux transporters
Löscher, W., & Potschka, H. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1728 · Cited by 900
Self-citationArtursson, P. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600790604 · Cited by 844
Chang, B. S., & Lowenstein, D. H. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022308 · Cited by 731
Evers, R., Kool, M., van Deemter, L., Janssen, H., Calafat, J., Oomen, L. C., Paulusma, C. C., Oude Elferink, R. P., Baas, F., Schinkel, A. H., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119886 · Cited by 620
Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases
Löscher, W., & Potschka, H. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.006 · Cited by 617
Self-citationDoan, K. M. M., Humphreys, J. E., Webster, L. O., Wring, S. A., Shampine, L. J., Serabjit-Singh, C. J., Adkison, K. K., & Polli, J. W. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039255 · Cited by 614
Schuetz, E. G., Beck, W. T., & Schuetz, J. D. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08713-9 · Cited by 494
Drug Resistance in Epilepsy: Putative Neurobiologic and Clinical Mechanisms
Schmidt, D., & Löscher, W. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.54904.x · Cited by 482
Self-citationCommunication between Multiple Drug Binding Sites on P-glycoprotein
Martin, C., Berridge, G., Higgins, C. F., Mistry, P., Charlton, P., & Callaghan, R. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12429-7 · Cited by 418
Molecular and cellular mechanisms of pharmacoresistance in epilepsy
Remy, S., & Beck, H. (2006) · Brain · doi:10.1093/brain/awh682 · Cited by 406
In vitro models for the blood–brain barrier
Garberg, P., Ball, M., Borg, N., Cecchelli, R., Fenart, L., Hurst, R. D., Lindmark, T., Mabondzo, A., Nilsson, J. E., Raub, T. J., et al. (2005) · Toxicology in Vitro · doi:10.1016/j.tiv.2004.06.011 · Cited by 394
Miller, D. S., Bauer, B., & Hartz, A. M. S. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.07109 · Cited by 392
(2001) · PubMed · Cited by 350
Pheophorbide a Is a Specific Probe for ABCG2 Function and Inhibition
Robey, R. W., Steadman, K., Polgar, O., Morisaki, K., Blayney, M., Mistry, P., & Bates, S. E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3298 · Cited by 350
Potential Role of Drug Transporters in the Pathogenesis of Medically Intractable Epilepsy
Kwan, P., & Brodie, M. J. (2005) · Epilepsia · doi:10.1111/j.0013-9580.2005.31904.x · Cited by 281
Rizzi, M., Caccia, S., Guiso, G., Richichi, C., Gorter, J. A., Aronica, E., Aliprandi, M., Bagnati, R., Fanelli, R., D'Incalci, M., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-14-05833.2002 · Cited by 243
Potschka, H., Fedrowitz, M., & Löscher, W. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00423-8 · Cited by 226
Self-citationBaltes, S., Gastens, A. M., Fedrowitz, M., Potschka, H., Kaever, V., & Löscher, W. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.07.038 · Cited by 223
Self-citationBrandt, C., Bethmann, K., Gastens, A. M., & Löscher, W. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.06.014 · Cited by 221
Self-citationAre MDCK Cells Transfected with the Human MDR1 Gene a Good Model of the Human Intestinal Mucosa?
Tang, F., Horie, K., & Borchardt, R. T. (2002) · Pharmaceutical Research · doi:10.1023/a:1016140429238 · Cited by 213
Santaguida, S., Janigro, D., Hossain, M., Oby, E., Rapp, E., & Cucullo, L. (2006) · Brain Research · doi:10.1016/j.brainres.2006.06.027 · Cited by 209
Van Vliet, E. A., Van Schaik, R., Edelbroek, P. M., Redeker, S., Aronica, E., Wadman, W. J., Marchi, N., Vezzani, A., & Gorter, J. A. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00496.x · Cited by 208
Potschka, H., Fedrowitz, M., & Löscher, W. (2001) · Neuroreport · doi:10.1097/00001756-200111160-00037 · Cited by 201
Self-citationThe Consequences of Uncontrolled Epilepsy
Sperling, M. R. (2004) · CNS Spectrums · doi:10.1017/s1092852900008464 · Cited by 201
Le Vee, M., Jigorel, E., Glaise, D., Gripon, P., Guguen-Guillouzo, C., & Fardel, O. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.01.004 · Cited by 190
Potschka, H., & Löscher, W. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.01901.x · Cited by 181
Self-citationMechanism of multidrug recognition by MDR1/ABCB1
Kimura, Y., Morita, S., Matsuo, M., & Ueda, K. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00538.x · Cited by 168
GIESSMANN, T., MAY, K., MODESS, C., WEGNER, D., HECKER, U., ZSCHIESCHE, M., DAZERT, P., GRUBE, M., SCHROEDER, E., & WARZOK, R. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.04.011 · Cited by 167
A functional in vitro model of rat blood–brain barrier for molecular analysis of efflux transporters
Perrière, N., Yousif, S., Cazaubon, S., Chaverot, N., Bourasset, F., Cisternino, S., Declèves, X., Hori, S., Terasaki, T., Deli, M., et al. (2007) · Brain Research · doi:10.1016/j.brainres.2007.02.091 · Cited by 163
Cucullo, L., Hossain, M., Rapp, E., Manders, T., Marchi, N., & Janigro, D. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2006.00960.x · Cited by 162
Baltes, S., Fedrowitz, M., Tortós, C. L., Potschka, H., & Löscher, W. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.102491 · Cited by 159
Self-citationCarbamazepine is not a substrate for P‐glycoprotein
Owen, A., Pirmohamed, M., Tettey, J. N. A., Morgan, P., Chadwick, D. W., & Park, B. K. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2001.01359.x · Cited by 146
Pharmacoresistance in Epilepsy: A Pilot PET Study with the P‐Glycoprotein SubstrateR‐[11C]verapamil
Langer, O., Bauer, M., Hammers, A., Karch, R., Pataraia, E., Koepp, M. J., Abrahim, A., Luurtsema, G., Brunner, M., Sunder‐Plaßmann, R., et al. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01116.x · Cited by 145
Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine
Oscarson, M., Zanger, U. M., Rifki, O. F., KLEIN, K., Eichelbaum, M. F., & Meyer, U. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.08.013 · Cited by 134
van Vliet, E. A., van Schaik, R., Edelbroek, P. M., Voskuyl, R. A., Redeker, S., Aronica, E., Wadman, W. J., & Gorter, J. A. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121178 · Cited by 117
Magnusson, M. O., Dahl, M.-L., Cederberg, J., Karlsson, M., & Sandström, R. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100431 · Cited by 90
Potschka, H., Baltes, S., & Löscher, W. (2004) · Epilepsy Research · doi:10.1016/j.eplepsyres.2003.12.007 · Cited by 88
Self-citationTaub, M. E., Kristensen, L. L., & Frøkjær, S. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00015-5 · Cited by 77
Eyal, S., Lamb, J. G., Smith-Yockman, M., Yagen, B., Fibach, E., Altschuler, Y., White, H. S., & Bialer, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706830 · Cited by 76
Vincristine transcriptional regulation of efflux drug transporters in carcinoma cell lines
Huang, R. S., Murry, D. J., Kolwankar, D., Hall, S. D., & Foster, D. R. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.03.009 · Cited by 75
Smith, A. J., Mayer, U., Schinkel, A. H., & Borst, P. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.15.1161 · Cited by 72
Kinetics of Penetration of Common Antiepileptic Drugs into Cerebrospinal Fluid
Löscher, W., & Frey, H. (1984) · Epilepsia · doi:10.1111/j.1528-1157.1984.tb04199.x · Cited by 56
Self-citationP-Glycoprotein—a Clinical Target in Drug-Refractory Epilepsy?
Robey, R. W., Lazarowski, A., & Bates, S. E. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.046680 · Cited by 55
Owen, A., Goldring, C. E., Morgan, P., Park, B. K., & Pirmohamed, M. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02587.x · Cited by 52
Brain regional pharmacokinetics of 11 ‐labeled diphenylhydantoin
Baron, J., Roeda, D., Munari, C., Crouzel, C., Chodkiewicz, J. P., & Comar, D. (1983) · Neurology · doi:10.1212/wnl.33.5.580 · Cited by 50
Takada, T., Suzuki, H., & Sugiyama, Y. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-1884-9 · Cited by 49
Pachot, J. I., Botham, R. P., Haegele, K. D., & Hwang, K. (2003) · PubMed · Cited by 49
Flanagan, S. D., Cummins, C. L., Susanto, M., Liu, X., Takahashi, L. H., & Benet, L. Z. (2002) · Pharmacology · doi:10.1159/000056161 · Cited by 48
COMPARISON OF DRUG EFFLUX TRANSPORT KINETICS IN VARIOUS BLOOD-BRAIN BARRIER MODELS
Bachmeier, C. J., Trickler, W. J., & Miller, D. W. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.006999 · Cited by 46
Brügger, D., Brischwein, K., Liu, C., Bader, P., NIETHAMMER, D., Gekeler, V., & Beck, J. F. (2002) · PubMed · Cited by 26
Cited by
Drug-Resistant Epilepsy: Multiple Hypotheses, Few Answers
Tang, F., Hartz, A. M. S., & Bauer, B. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00301 · Cited by 482
The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs
Shugarts, S., & Benet, L. Z. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9924-0 · Cited by 438
Very important pharmacogene summary
Hodges, L. M., Markova, S. M., Chinn, L. W., Gow, J. M., Kroetz, D. L., Klein, T. E., & Altman, R. B. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283385a1c · Cited by 436
Antiepileptic drug interactions—Principles and clinical implications
I. Johannessen, S., & Johannessen Landmark, C. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246254 · Cited by 343
Hoshi, Y., Uchida, Y., Tachikawa, M., Inoue, T., Ohtsuki, S., & Terasaki, T. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23575 · Cited by 254
Metadata
- Authors
- Luna-Tortós, C., Fedrowitz, M., & Löscher, W.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2008-12
- Volume
- 55
- Issue
- 8
- Pages
- 1364-1375
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W1993337516
- Cited by
- 310
- References
- 57
- FWCI
- 12.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.